Vyxeos
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Vyxeos, covering 2017-08-03 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms [Phase 1, Phase 2]